4/11/2018 | HY | Market Commentary: TopBuild upsizes; Drax on tap; Hilton dominates; energy sector outperforms; HCA active
|
4/18/2017 | HY | Market Commentary: Cumberland prices; Petsmart surges on Chewy acquisition; Post up a bit after buying Weetabix; pharma down
|
11/9/2016 | HY | Market Commentary: Morning Commentary: Junk bonds mixed in post-election trading; bonds of regulated industries gain
|
10/18/2016 | HY | Market Commentary: Industrial metals rally; energy names bounce; Sprint debt continues to roll following preliminary results
|
8/9/2016 | HY | Market Commentary: Builders First Source leads continued drive-by parade, new bonds pop; Valeant jumps on results, guidance
|
8/8/2016 | HY | Market Commentary: Hilton megadeal, Graphic Packaging drive by, split-rated HCA, NXP also; recent Adient stays firm
|
8/8/2016 | HY | Market Commentary: Hilton megadeal, Graphic Packaging drive by, split-rated HCA, NXP also; recent Adient stays firm
|
8/8/2016 | HY | New Issue: HCA upsizes to $1.2 billion, prices 10.5-year secured bullet at par to yield 4½%
|
8/8/2016 | HY | HCA guiding $1 billion 10.5-year secured bullet notes in 4¾% area; pricing Monday
|
3/17/2016 | BKBWHYLW | HCA says balance sheet is strong, will continue to buy back stock
|
3/8/2016 | HY | Market Commentary: Upsized Level 3 drives by, trades busily, active GameStop retreats; energy, iron-ore credits lower
|
3/8/2016 | CLHY | Market Commentary: HCA breaks atop OID; AWAS Finance, PDC Brands set price talk; Survey Sampling OID surfaces
|
3/4/2016 | CLHY | Market Commentary: KAR Auction updated, breaks; AMC term B steady with acquisition news; HCA tweaks deal
|
3/2/2016 | HY | Market Commentary: Primary quiet; GameStop shops deal; HCA jumps in heavy trading; steel makers up on trade ruling
|
3/1/2016 | HY | Market Commentary: Upsized HCA megadeal drives by, bonds rise; new Solera strong; Valeant rebounds, Intelsat fall persists
|
3/1/2016 | CLHY | Market Commentary: Valeant Pharmaceuticals sees some improvement; Solera gains; HCA reworks term loan size
|
2/29/2016 | CLHY | Market Commentary: Solera breaks; Intelsat retreats with amendment request; Federal-Mogul up on Icahn offer
|
2/26/2016 | CLHY | Market Commentary: Vivid Seats, MedRisk emerge in secondary; Caliber Collision trades higher; Solera revised
|
1/11/2016 | BKBWHY | HCA Holdings ups adjusted EBITDA guidance for 2015, admissions rise
|
12/4/2015 | HY | Market Commentary: Downsized ClubCorp caps $4 billion primary week; recent bonds busy; Chesapeake slide continues
|
12/3/2015 | HY | Market Commentary: HCA, Aramark, Group 1 price; new bonds busy; Chesapeake off on swap; funds gain $398 million
|
12/3/2015 | BKHY | Fitch rates HCA add-on BB
|
10/24/2015 | HY | Market Commentary: Valeant leads pharma, hospitals rebound; Asbury Auto add-on closes $1.65 billion primary week
|
10/23/2015 | HY | Market Commentary: Hospital names fall on Community Health earnings warning; junk funds see $3.34 billion inflow
|
10/22/2015 | HY | Market Commentary: Valeant, other drug makers continue slide; hospital names trade off; energy credits lower
|
9/21/2015 | BKHY | Moody’s upgrades HCA
|
5/7/2015 | HYLM | HCA Holdings calls all $1.53 billion outstanding 7¾% notes due 2021
|
5/6/2015 | HYLM | HCA plans to redeem $1.53 billion 7¾% notes due 2021 via new issue
|
1/14/2015 | HY | Market Commentary: Level 3 drives by, Ziggo also prices; HCA megadeal stays busy; overall market lower
|
1/13/2015 | HY | Market Commentary: HCA, Virgin Media, SunCoke Energy price, head higher; energy names off as oil slides again
|
1/13/2015 | BKHY | Moody's rates HCA notes B2
|
10/8/2014 | HYLM | HCA to redeem in full $1.4 billion of 7¼% secured notes on Nov. 6
|
10/7/2014 | BKHY | Moody's rates HCA notes Ba2
|
10/7/2014 | HYLM | HCA Holdings to repurchase all $1.4 billion of 7¼% notes via offering
|
10/1/2014 | HY | Moody’s upgrades HCA, debt
|
6/18/2014 | BKBWHYLW | HCA Holdings eyes further expansion through acquisitions, says CFO
|
5/20/2014 | BKHY | Fitch: HCA unchanged
|
3/4/2014 | BKHY | HCA Holdings expects to spend $2.2 billion on growth initiatives in 2014, says CFO
|
10/30/2013 | BKHY | Fitch: HCA Holdings unchanged
|
6/27/2013 | HY | Market Commentary: Valeant megadeal, Solera drive-by price; new Valeant paper jumps; funds slide by $3.1 billion
|
2/5/2013 | BKHY | HCA reports $29 billion of debt at year's end; leverage down slightly
|
12/13/2012 | BKHY | HCA Holdings' use of cash includes capital, dividends and acquisitions
|
12/7/2012 | HY | Market Commentary: Prince, Tops, Kenan, Rex among deals pricing to conclude $10 billion week
|
12/6/2012 | HY | Market Commentary: MGM, Caesars set pace for $3 billion primary; overall market firm; junk funds see second inflow
|
12/5/2012 | HY | Market Commentary: Hamilton Sundstrand deal prices, gains; Plains Exploration zooms on sale to Freeport-McMoRan
|
12/4/2012 | HY | Market Commentary: Cinemark, NCR, Targa drive-bys pace $1.3 billion session; new HCA bonds move up
|
12/3/2012 | HY | New Issue: HCA prices $1 billion bullet notes due 2021 at par to yield 61/4%
|
12/3/2012 | HY | Fitch: HCA Holdings notes B-
|
12/3/2012 | HY | Market Commentary: HCA drive-by megadeal prices, firms; upsized McClatchy comes as year-end rush starts to build
|
12/3/2012 | BKHY | Moody's rates HCA notes B3, loan Ba3
|
12/3/2012 | BKHY | S&P: HCA Holdings notes B-
|
12/3/2012 | HY | HCA pricing $1 billion bullet deal Monday to fund special dividend
|